|
Depression Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 147 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Depression Global Clinical Trials Review, H1, 2012" provides data on the Depression clinical trial scenario. This report provides elemental informati.....
Introduction GlobalData's clinical trial report, “Depression Global Clinical Trials Review, H1, 2012" provides data on the Depression clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Depression. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Depression. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Depression 7 Report Guidance 7 Clinical Trials by Region 8 Clinical Trials by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14 Top Five Countries Contributing to Clinical Trials in Central and South America 15 Clinical Trials by BRIC Nations 16 Clinical Trials by G7 Nations 17 Clinical Trials in G7 Nations by Trial Status 18 Clinical Trials by E7 Nations 19 Clinical Trials in E7 Nations by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Unaccomplished Trials of Depression 24 Subjects Recruited Over a Period of Time 34 Prominent Sponsors 35 Top Companies Participating in Depression Therapeutics Clinical Trials 37 Prominent Drug Comparison 39 Clinical Trial Profiles 40 Clinical Trial Overview of Top Companies 40 Eli Lilly and Company 40 Clinical Trial Overview of Eli Lilly and Company 40 Pfizer Inc. 47 Clinical Trial Overview of Pfizer Inc. 47 AstraZeneca PLC 54 Clinical Trial Overview of AstraZeneca PLC 54 GlaxoSmithKline plc 60 Clinical Trial Overview of GlaxoSmithKline plc 60 Johnson & Johnson 65 Clinical Trial Overview of Johnson & Johnson 65 Bristol-Myers Squibb Company 68 Clinical Trial Overview of Bristol-Myers Squibb Company 68 Sanofi 70 Clinical Trial Overview of Sanofi 70 Merck & Co., Inc. 72 Clinical Trial Overview of Merck & Co., Inc. 72 Forest Laboratories, Inc. 74 Clinical Trial Overview of Forest Laboratories, Inc. 74 Novartis AG 76 Clinical Trial Overview of Novartis AG 76 H. Lundbeck A/S 78 Clinical Trial Overview of H. Lundbeck A/S 78 Otsuka Pharmaceutical Co., Ltd. 80 Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 80 Sandoz Inc. 82 Clinical Trial Overview of Sandoz Inc. 82 Takeda Pharmaceutical Company Limited 84 Clinical Trial Overview of Takeda Pharmaceutical Company Limited 84 Teva Pharmaceuticals USA, Inc. 85 Clinical Trial Overview of Teva Pharmaceuticals USA, Inc. 85 Boehringer Ingelheim GmbH 86 Clinical Trial Overview of Boehringer Ingelheim GmbH 86 Abbott Laboratories 87 Clinical Trial Overview of Abbott Laboratories 87 Teva Pharmaceutical Industries Limited 88 Clinical Trial Overview of Teva Pharmaceutical Industries Limited 88 Roxane Laboratories, Inc. 89 Clinical Trial Overview of Roxane Laboratories, Inc. 89 Torrent Pharmaceuticals Limited 90 Clinical Trial Overview of Torrent Pharmaceuticals Limited 90 Clinical Trial Overview of Top Universities / Institutes / Hospitals 91 Massachusetts General Hospital 91 Clinical Trial Overview of Massachusetts General Hospital 91 University of Pittsburgh 96 Clinical Trial Overview of University of Pittsburgh 96 Stanford University 98 Clinical Trial Overview of Stanford University 98 The University of Texas Southwestern Medical Center at Dallas 100 Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas 100 University of California, Los Angeles 102 Clinical Trial Overview of University of California, Los Angeles 102 New York State Psychiatric Institute 104 Clinical Trial Overview of New York State Psychiatric Institute 104 U.S. Department of Veterans Affairs 106 Clinical Trial Overview of U.S. Department of Veterans Affairs 106 The University of New South Wales 109 Clinical Trial Overview of The University of New South Wales 109 Vanderbilt University 111 Clinical Trial Overview of Vanderbilt University 111 Mclean Hospital 112 Clinical Trial Overview of Mclean Hospital 112 The University of British Columbia 113 Clinical Trial Overview of The University of British Columbia 113 Department of Health 114 Clinical Trial Overview of Department of Health 114 University of Cincinnati 116 Clinical Trial Overview of University of Cincinnati 116 Duke University 117 Clinical Trial Overview of Duke University 117 INSTITUT DE RECHERCHES INTERNATIONALES SERVIER 118 Clinical Trial Overview of INSTITUT DE RECHERCHES INTERNATIONALES SERVIER 118 Yale University 121 Clinical Trial Overview of Yale University 121 University Health Network 122 Clinical Trial Overview of University Health Network 122 Emory University 123 Clinical Trial Overview of Emory University 123 University of California, San Francisco 124 Clinical Trial Overview of University of California, San Francisco 124 Sheba Medical Center 125 Clinical Trial Overview of Sheba Medical Center 125 Five Key Clinical Profiles 126 Appendix 144 Abbreviations 144 Definitions 144 Research Methodology 145 Secondary Research 146 About GlobalData 146 Contact Us 146 Disclaimer 146 Source 147 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Depression Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8 Depression Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Depression Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Depression Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11 Depression Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12 Depression Therapeutics Clinical Trials, North America, Top Countries, 2012* 13 Depression Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 14 Depression Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15 Depression Therapeutics Clinical Trials, BRIC Countries, 2012* 16 Depression Therapeutics Clinical Trials, G7 Countries, 2012* 17 Depression Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Depression Therapeutics Clinical Trials, E7 Countries, 2012* 19 Depression Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Depression Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21 Depression Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22 Depression Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Depression Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24 Depression Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25 Depression Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27 Depression Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 34 Depression Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 36 Depression Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 38 Depression Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 39 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 40 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 47 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 54 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 60 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 65 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 68 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 70 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 72 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2012* 74 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 76 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2012* 78 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2012* 80 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Sandoz Inc., 2012* 82 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012* 84 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceuticals USA, Inc., 2012* 85 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012* 86 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 87 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2012* 88 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Roxane Laboratories, Inc., 2012* 89 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Torrent Pharmaceuticals Limited, 2012* 90 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 91 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 96 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 98 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Southwestern Medical Center at Dallas, 2012* 100 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 102 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2012* 104 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2012* 106 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2012* 109 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012* 111 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2012* 112 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2012* 113 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, 2012* 114 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2012* 116 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 117 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by INSTITUT DE RECHERCHES INTERNATIONALES SERVIER, 2012* 118 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2012* 121 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012* 122 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012* 123 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 124 Depression Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2012* 125 List of Figures Depression Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8 Depression Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Depression Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Depression Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11 Depression Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12 Depression Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13 Depression Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 14 Depression Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15 Depression Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16 Depression Therapeutics Clinical Trials, G7 Countries (%), 2012* 17 Depression Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Depression Therapeutics Clinical Trials, E7 Countries (%), 2012* 19 Depression Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Depression Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21 Depression Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22 Depression Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Depression Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 34 Depression Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 35 Depression Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 37 Depression Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 39 GlobalData Methodology 145 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
